Delivery Order SPE2DB25D3020-SPE2DB25FWJPC
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,253.69 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Gemtesa 75 mg, with a ceiling value of $15,610.65 under a firm fixed-price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gemtesa 75 mg tablets in quantities of 90, with a total ceiling value of $8,669.82 and a final completion date of July 3, 2025. The contract is not set aside and was awarded on July 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Gemtesa 75 mg tablets in quantities of 90s. The completion date is February 23, 2024, and the potential value of the award is $2,069.04. This delivery order is issued under a larger indefinite delivery contract (IDC) held...
- The Defense Logistics Agency awarded a delivery order valued at $43,249.13 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count packages) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription medication used in the treatment of overactive...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $13,069.24 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of January 9, 2024, is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. This Delivery Order contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The $7,572.53 contract has an ultimate completion date of November 24, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of pharmaceutical products...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The contract has a firm fixed price of $7,763.54 and an ultimate completion date of March 6, 2025. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp, a for-profit organization, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $8,165.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gemtesa 75 mg tablet, a prescription medication, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a $11,196.94 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of March 19, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...